Hetero launches its generic semaglutide portfolio in international markets, enhancing access to advanced diabetes and obesity therapies. Hetero has launched its generic semaglutide portfolio in
Ultra-low dose of cancer meds works, reduces costs by 90%, finds Tata studyThe Parel-based premier cancer hospital found that giving one-tenth of the standard dosage
The eagerly anticipated semaglutide patent cliff in India has unleashed a strikingly varied pricing landscape. The intensity of the price decline is driven by the
As a persistent LPG shortage disrupts traditional cooking across India, consumers are rapidly pivoting toward convenience. Amazon India has reported a significant spike in demand
Hindustan Unilever Limited (HUL) has formally denied rumours regarding the potential sale of its foods division, labeling the segment as a “core and attractive” pillar
RESEARCH TRIANGLE PARK, NC, January 27, 2026 – BASF is further expanding its industry-leading seed portfolio with the addition of three new Stoneville® cotton varieties
Suresh L.M., who is an alumnus of the University of Agricultural Sciences, Bengaluru, was honoured recently in Nairobi for playing a key role in fighting
New Delhi: Medicine prices in India may rise sharply amid a 30% surge in the cost of key raw materials or active pharma ingredients in
With the patent protection for Novo Nordisk’s best-selling medicine semaglutide expiring in India, at least eight Indian companies on Saturday launched cheaper, generic versions of
Hyderabad-based Natco Pharma has launched its generic semaglutide injection in India at a starting price of Rs 1,290 per month, marking one of the cheapest
Copyright © 2025 Gubba Cold Storage Ltd, All rights reserved. Designed, Developed by TenJump